Skip to main content

Table 3 The univariate and multivariate analysis of factors related to progression free survival and overall survival

From: Additional chemotherapy improved local control and overall survival after stereotactic body radiation therapy for patients with oligo-recurrence

 

Progression free survival

Overall survival

 

Univariate (p value)

Multivariate (p value)

Hazard ratio (95%CI)

Univariate (p value)

Multivariate (p value)

Hazard ratio (95%CI)

Age: ≥ 70 vs < 70

0.195

  

0.638

  

Gender: male vs female

0.607

  

0.774

  

ECOG PS: 0 vs 1–2

0.435

  

0.866

  

Lesion number: single vs multiple

0.008

0.010

0.46 (0.26–0.83)

0.053

0.112

0.43 (0.15–1.22)

Histology: CRC vs others

0.496

  

0.935

  

Previous chemotherapy: yes vs no

0.378

  

0.927

  

Posterior chemotherapy: yes vs no

0.088

0.126

1.60 (0.88–2.93)

0.035

0.078

2.72 (0.90–8.27)

  1. ECOG Eastern Cooperative Oncology Group, PS performance status, CRC colorectal cancer, CI confidence interval